ClinicalTrials.gg
RecruitingNCT07629674SI-VI-MIUpdated Jul 13, 2026

Visual Stimulation Through Video Therapy to Enhance Lower Limb Motor Recovery After Stroke

An interventional study of Active Videotherapy and Sham videotherapy in Hemiparetic Stroke, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Recruiting at 1 site in France. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-07-13.

Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Stroke by Centre Hospitalier Universitaire de Saint Etienne — 4 open to participants now, 6 under way, none of them phase 3. Stroke · Centre Hospitalier Universitaire de Saint Etienne.

Planned enrollment
11th of 13
12 · median 37
Started
2026
the only one that year
No phase
13 of 18
4 open now
Registered
16th of 18
by date

Among the 18 studies in Stroke by Centre Hospitalier Universitaire de Saint Etienne, this one is the 11th largest by planned enrollment of the 13 interventional ones that give a count, is the only one that started in 2026, is one of 13 with no phase, and was the 16th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

4 of the 18 studies in Stroke by Centre Hospitalier Universitaire de Saint Etienne are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Stroke by Centre Hospitalier Universitaire de Saint Etienne, or all of them as a file.
02

Study summary

This pilot study evaluates video therapy for lower limb motor recovery after stroke, an approach remains insufficiently documented.

This single-center pilot study uses a Single-Case Experimental Design (SCED) to evaluate the effects of intensive video therapy combined with conventional rehabilitation in patients with subacute or chronic post-stroke hemiparesis. Twelve participants will be included and allocated to different baseline durations according to a multiple-baseline SCED design.

The primary outcome is functional mobility, assessed using the Timed Up and Go (TUG) test, measured repeatedly throughout baseline, intervention, and follow-up phases.

Read the detailed description

Stroke frequently results in persistent lower limb motor impairment affecting gait and functional mobility (1-2). While video-based therapies have shown proof of concept for upper limb rehabilitation after stroke, their effectiveness for lower limb motor recovery remains insufficiently documented (3-5).

This study is a single-center pilot trial using a Single-Case Experimental Design (SCED) with multiple baseline durations, chosen to account for the high interindividual variability observed in subacute and chronic post-stroke patients undergoing rehabilitation (6). This design allows each participant to serve as their own control through repeated measurements over time (6).

Participants are included between 1 month and 1 year post-stroke while receiving inpatient or outpatient rehabilitation in a Physical Medicine and Rehabilitation department. All participants initially undergo a control phase combining standardized rehabilitation with sham video therapy (placebo condition). The duration of this baseline phase is randomized (1, 2, or 3 weeks) across participants.

The experimental phase consists of 5 weeks of intensive video therapy added to usual care, with five sessions per week. A post-intervention sham phase is followed by a follow-up period lasting up to 21 weeks post-intervention, with repeated assessments conducted at weeks 13, 17, and 21 to evaluate maintenance of treatment effects.

The primary objective is to evaluate changes in functional mobility, assessed using repeated measurements of the Timed Up and Go test. Secondary objectives include evaluation of gait endurance, motor impairment, muscle tone, balance, and quality of life

.

03

Conditions studied

  • Hemiparetic Stroke

Browse trials for

Keywords

  • Videotherapy
  • Lower limb rehabilitation
  • Hemiplegic/Hemiparetic
  • Single case experimental design
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • - First or recurrent hemispheric ischemic or hemorrhagic stroke in the subacute or chronic phase (from 1 month to 1 year post-stroke).
  • Currently receiving rehabilitation care in a Physical Medicine and Rehabilitation (PM\&R) department
  • Able to walk 3 meters back and forth, with or without an assistive device.
  • Provided , signed jointly with the investigator.

Exclusion criteria

Exclusion Criteria:

  • - Severe hemispatial neglect.
  • Severe spasticity impairing proper positioning (Modified Ashworth Scale > 3).
  • Severe general disabling medical conditions.
  • Associated cerebellar syndrome.
  • Major comprehension disorders, psychiatric illness, or cognitive impairments that could interfere with study participation.
  • Participants under full legal guardianship (tutorship).
  • Pregnant or breastfeeding women.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Participant)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Sequence 1

    1 week of sham videotherapy , 5 weeks of intervention (active videotherapy) , 2 weeks of sham videotherapy.

    Device: Active Videotherapy · Device: Sham videotherapy

  • Experimental
    Sequence 2

    2 weeks of sham videotherapy , 5 weeks of intervention (active videotherapy) , 1 weeks of sham videotherapy.

    Device: Active Videotherapy · Device: Sham videotherapy

  • Experimental
    Sequence 3

    3 weeks of sham videotherapy and 5 weeks of intervention (active videotherapy) ,

    Device: Active Videotherapy · Device: Sham videotherapy

Interventions

  • DeviceActive Videotherapy

    During active videotherapy sessions, the image inversion program is activated, superimposing movements of the non-paretic limb onto the paretic limb, which is hidden behind the screen. Participants are instructed to imagine and attempt to reproduce the observed movements using their paretic limb. Each participant completes 25 sessions over 5 weeks (5 sessions per week).

  • DeviceSham videotherapy

    During sham videotherapy sessions, participants are seated facing the IVS4 screen without activation of the image inversion program. Participants perform lower limb movements while directly viewing their paretic limb in real time on the screen, corresponding to an action observation condition without visual illusion.

06

What researchers measure

Primary outcomes

  1. 1. Timed Up and Go Test (TUG)

    Time required to stand up from a chair, walk 3 meters, return, and sit down (in seconds)

    Time frame: 5-week

Secondary outcomes

  1. 2. 2-Minute Walk Test (2MWT)

    Walking endurance assessed by the distance walked in 2 minutes (in meters).

    Time frame: Weeks 1, 2, 3, 8, 13, 17, and 21

  2. 3. Fugl-Meyer Assessment - Lower Limb Section

    Motor function of the hemiplegic lower limb, assessed with the Fugl-Meyer scale (score from 0 to 34)

    Time frame: Weeks 1, 2, 3, 8, 13, 17, and 21

  3. 4. Muscle Strength - Foot Dorsiflexors and extensors

    Muscle strength of the foot dorsiflexors and extensors, measured in Newtons using a handheld dynamometer

    Time frame: Weeks 1, 2, 3, 8, 13, 17, and 21

  4. 5. Muscle Tone - Modified Ashworth Scale (MAS)

    Spasticity assessment of dorsiflexors and extensors of the foot using the Modified Ashworth Scale (score 0-5).

    Time frame: Weeks 1, 2, 3, 8, 13, 17, and 21

  5. 6. Muscle Tone - Modified Tardieu Scale

    Spasticity assessment of dorsiflexors and extensors of the foot using the Modified Tardieu Scale (score 0-5).

    Time frame: Weeks 1, 2, 3, 8, 13, 17, and 21

  6. 7. Postural Balance - PASS (Postural Assessment Scale for Stroke Patients)

    Balance ability assessed using the PASS scale (score 0-36).

    Time frame: Weeks 1, 2, 3, 8, 13, 17, and 21

  7. 8. Quality of Life - Stroke Specific Quality of Life Scale (SS-QOL)

    Quality of life assessed with the SS-QOL scale (score range: 49-245).

    Time frame: Weeks 1, 2, 3, 8, 13, 17, and 21

07

Study locations

1 of 1 sites recruiting
  • Service de Médecine Physique et réadaptation
    Saint-Etienne, 42100, France
    Recruiting
    • Diana RIMAUD, PhD · ContactDiana.Rimaud@chu-st-etienne.fr · 04 77 12 04 67
    • Pascal GIRAUX, MD, PhD · Sub investigator
    • Etienne OJARDIAS, MD · Principal investigator
    • Hugo BESSAGUET, MD · Sub investigator
    • Julia TOULY, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — This study has only 1 center

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Dec 2027, 17 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 17 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 21, 2026
First posted
Jun 5, 2026
StartActual
Jul 9, 2026
Primary completionEst.
Dec 31, 2027
CompletionEst.
Jun 30, 2028
Last update
Jul 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07629674
Responsible party
Arnauld GARCIN (Dr, Centre Hospitalier Universitaire de Saint Etienne) — Principal investigator
First posted
Jun 5, 2026
Start date
Jul 9, 2026
Primary completion
Dec 31, 2027 (estimated)
Completion
Jun 30, 2028 (estimated)
Last update
Jul 13, 2026

Study contacts

Etienne OJARDIAS, Dr
Contact
Etienne.Ojardias@chu-st-etienne.fr
0477127018 ext. 33
Etienne OJARDIAS, Dr
principal investigator · Centre Hospitalier Universitaire de Saint Etienne

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion